Form4insider filings, from the source

SEC Form 4 · accession 0001225208-15-012345

Edwards Lifesciences Corp · EW

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Huimin Wang
Officer — CVP, Japan & Intercontinental
Period of report
May 14, 2015
Accepted (ET)
May 18, 2015 · 6:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2May 14, 2015A1,175$0.00A34,081D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (Right to Acquire)F3$130.56May 14, 2015A12,700AJun 14, 2015May 13, 2022Common Stock12,70012,700D
Performance RightsF4,F2—May 14, 2015A1,475A—May 31, 2018Common Stock1,4751,475D

Explanation of responses